TELIGEN
Report
- Report Number
- 2124215-2011-03369
- Event Type
- Injury
- Date Received
- April 12, 2011
- Date of Event
- February 22, 2011
- Report Date
- August 12, 2011
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
ALL AVAILABLE INFORMATION INDICATES THAT THE DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE PRODUCT WAS PERFORMED. THE DEVICE HAD NO TELEMETRY UPON RETURN. THE DEVICE CASE WAS OPENED. AN EXTERNAL POWER SUPPLY WAS CONNECTED TO THE DEVICE AND THE ELECTRICAL CURRENT WAS MONITORED. DURING THE MONITORING PROCESS A HIGH CURRENT CONDITION WAS OBSERVED. ELECTRICAL TESTING AND ANALYSIS WERE THEN CONDUCTED, WHICH ISOLATED THE HIGH CURRENT TO AN ANOMALY ON ONE OF THE COMPONENT LAYERS (GATE OXIDE) WITHIN AN INTEGRATED CIRCUIT. THIS ANOMALY CAUSES A HIGH CURRENT DRAIN, WHICH OVER TIME RESULTED IN THE REPORTED CLINICAL OBSERVATION.
ADDITIONAL INFORMATION WAS RECEIVED THAT AS A RESULT OF NEVER BEING ABLE TO COMMUNICATE OR OBTAIN TELEMETRY, THIS DEVICE WAS EXPLANTED AND REPLACED. ONCE THE DEVICE WAS EXPLANTED, TELEMETRY WAS NOT ACHIEVED.
THE PATIENT WAS BROUGHT INTO THE CLINIC AND THE DEVICE WAS UNABLE TO BE INTERROGATED WHEN USING MULTIPLE PROGRAMMERS. THE RF ANTENNA ON THE DEVICE WAS OBSERVED TO BE POINTED INWARD. TECHNICAL SERVICES DISCUSSED RECOMMENDATIONS TO INTERROGATE THE DEVICE. A MAGNET WAS PLACED OVER THE DEVICE, HOWEVER, NO TONES WERE PRODUCED. IT WAS NOTED THAT THE PATIENT IMPLANTED WITH THIS DEVICE WAS LARGE BREASTED AND THE DEVICE HAD POSSIBLY MIGRATED. AN XRAY OF THE DEVICE DISPLAYED THAT THE LEADS WERE TWISTED AND THE DEVICE HAD MIGRATED. THE PATIENT'S PHYSICIAN SENT THE PATIENT HOME TO INTERROGATE VIA THE LATITUDE HOME MONITORING SYSTEM, HOWEVER, THE DEVICE WAS NOT ABLE TO BE INTERROGATED VIA LATITUDE.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS UNABLE TO BE INTERROGATED. THE PATIENT WAS TO BE BROUGHT IN FOR FURTHER EVALUATION IN ONE WEEK. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED WITH THIS CLINICAL OBSERVATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Hospitalization| L| R | E110| T165| 4479| 0184 |